The study of inhibiting systematic inflammatory response syndrome by applying xenogenic (porcine) acellular dermal matrix on second-degree burns

Burns. 2007 Jun;33(4):477-9. doi: 10.1016/j.burns.2006.08.011. Epub 2007 Feb 28.

Abstract

Objective: To investigate the influence of xenogenic (porcine) acellular dermal matrix on the systematic inflammatory reaction syndrome (SIRS), and the reaction of burn patients to tissue damage upon application to second-degree burn wounds.

Method: Seventy-two cases of patients with acute second-degree burns were enrolled in the study. According to the total burn surface area (TBSA) and the treatment methods, we randomly divided the patients into four groups. Group A (treatment group): patients with less than 30% TBSA covered with xenogenic acellular dermal matrix. Group B (control group): patients with less than 30% TBSA covered with betadine ointment gauzes. Group C (treatment group): patients with more than 30% TBSA covered with porcine acellular dermal matrix. Group D (control group): patients with more than 30% TBSA covered with betadine ointment gauzes. Serum level of C-reactive protein (CRP) was measured by single radial immunodiffusion method on 1, 4, 7 and 14 days postburn.

Results: The serum level of CRP in group A was significantly less than that of in group B (P<0.05) on days 4, 7 and 14. The serum level of CRP in group C increased slowly, descended quickly and was significantly less than that of in group D on days 4, 7 and 14.

Conclusion: The application of xenogenic (porcine) acellular dermal matrix on second-degree burn wound can decrease serum level of CRP of the patients, which may play an important role in reducing SIRS and sepsis incidence.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Adolescent
  • Adult
  • Animals
  • Biological Dressings*
  • Burns / blood
  • Burns / therapy*
  • C-Reactive Protein / metabolism
  • Child
  • Child, Preschool
  • Dermis / transplantation*
  • Humans
  • Infant
  • Middle Aged
  • Skin, Artificial
  • Swine
  • Systemic Inflammatory Response Syndrome / blood
  • Systemic Inflammatory Response Syndrome / prevention & control*
  • Transplantation, Heterologous

Substances

  • C-Reactive Protein